Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stat5 as a diagnostic marker for leukemia.

Rowena S Lewis1, Alister C Ward

  • 1Cancer & Haematology Division, The Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, 3050, Australia. lewis@wehi.edu.au

Expert Review of Molecular Diagnostics
|December 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytokine inducible SH2-containing protein: a versatile negative regulator of cytokine receptor signaling.

Frontiers in immunology·2026
Same author

The Interleukin-7 Receptor Signaling Pathway and Its Perturbation in Immunodeficiency, Autoimmune Disease and Lymphoid Malignancy.

Biomolecules·2026
Same author

Colony-Stimulating Factor 3 Receptor Mutations and Variants in Hematological Malignancies.

Cancers·2025
Same author

Cytokine Receptor-like Factor 3 (CRLF3) and Its Emerging Roles in Neurobiology, Hematopoiesis and Related Human Diseases.

International journal of molecular sciences·2025
Same author

Socs3a is Dispensable for Zebrafish Hematopoiesis and is Required for Neuromast Formation.

Frontiers in bioscience (Landmark edition)·2025
Same author

The Interplay of Nutrition, the Gut Microbiota and Immunity and Its Contribution to Human Disease.

Biomedicines·2025
Same journal

Bacterial respiratory infections: advances in diagnostic strategies.

Expert review of molecular diagnostics·2026
Same journal

Artificial intelligence in molecular diagnostics for pandemic preparedness.

Expert review of molecular diagnostics·2026
Same journal

Navigating PD-L1 testing in immuno-oncology: analytical robustness, clinical validation, and the role of the VENTANA SP263 assay.

Expert review of molecular diagnostics·2026
Same journal

Extracellular vesicles as diagnostic and prognostic biomarkers in non-small cell lung cancer.

Expert review of molecular diagnostics·2026
Same journal

Explainable epigenetic aging clocks: an overview of existing AI models and approaches.

Expert review of molecular diagnostics·2026
Same journal

Neuro-axonal injury biomarker serum neurofilament light chain is associated with osteoarthritis: a dual-cohort study from NHANES and UK Biobank.

Expert review of molecular diagnostics·2026
See all related articles

The Janus kinase-Signal transducer and activator of transcription-Suppressor of cytokine signaling (Jak-Stat-Socs) pathway regulates cytokine signaling. Stat5 activation is implicated in various leukemias and myeloproliferative disorders, making it a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Immunology
  • Oncology

Background:

  • The Jak-Stat-Socs pathway is crucial for cytokine receptor signaling.
  • Dysregulation of this pathway is linked to hematopoietic and immune diseases like leukemia and lymphoma.

Purpose of the Study:

  • To review the role of Signal transducer and activator of transcription 5 (Stat5) in the Jak-Stat-Socs pathway.
  • To explore Stat5's involvement in leukemias and myeloproliferative disorders.

Main Methods:

  • Literature review focusing on Stat5 activation and its downstream effects.
  • Analysis of Stat5's role in oncogenesis and disease pathogenesis.

Main Results:

  • Stat5 activation is observed in various leukemias and myeloproliferative disorders.

Related Experiment Videos

  • Stat5 plays a key role in mediating the effects of oncogenes in these conditions.

    • Conclusions:

    • Stat5 is a potential pan-leukemia/myeloproliferative disorder diagnostic marker.
    • Stat5 represents a significant therapeutic target and endpoint for these hematologic malignancies.